1 Study Matches
BHV-0223 Expanded Access Protocol in Patients with Amyotrophic Lateral Sclerosis
This is an Expanded Access Protocol (EAP) to provide a new version of riluzole that is placed under the tongue (sublingual) rather than swallowed.
18 year(s) or older
Inclusion Criteria:Diagnosed with ALS
Swallowing difficulties OR choking at least once per week
Other serious medical condition that would interfere with your participation